Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|February 8, 2021
Recent development in the discovery of PARP inhibitors as anticancer agents: a patent update (2016-2020)Uday Kiran Velagapudi, Bhargav A Patel, Xuwei Shao, et al.
Journal of Medicinal Chemistry|October 5, 2019
Chemical Space Exploration around Thieno[3,2-d]pyrimidin-4(3H)-one Scaffold Led to a Novel Class of Highly Active Clostridium difficile InhibitorsXuwei Shao, Ahmed AbdelKhalek, Nader S Abutaleb, et al.
Journal of Medicinal Chemistry|December 19, 2017
Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-GlycoproteinBhargav A Patel, Biebele Abel, Anna Maria Barbuti, et al.
The Biochemical Journal|February 19, 2024
Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaksUday Kiran Velagapudi, Élise Rouleau-Turcotte, Ramya Billur, et al.
Science (New York, N.Y.)|April 4, 2020
Structural basis for allosteric PARP-1 retention on DNA breaksLevani Zandarashvili, Marie-France Langelier, Uday Kiran Velagapudi, et al.
Pageof 1